Medtronic Receives FDA Approval of Spinal Cord Stimulator

September 20, 2017

Medtronic received FDA approval of the Intellis platform for the management of certain types of chronic pain.

The device is placed under a patient's skin to deliver mild electrical impulses through a lead implanted in the epidural space to block pain signals from going to the brain.

The device tracks and records patient activity 24/7 and is managed on the Samsung Galaxy Tab S2 tablet interface, enabling physicians to monitor progress and make modifications to suit their patients' therapy needs.

View today's stories